ArticleClinical Medicine Insights. Oncology2024

An Active Trend of Immunotherapy Combination Regimen as Second-Line Therapy Towards Advanced Biliary Tract Cancer.

Haimin Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.